Which chemical are you lacking in depression?

Depression is a complex, multifactorial condition in which several neurotransmitters—most notably serotonin, dopamine, GABA and norepinephrine—play central roles. Recent research emphasizes the gut-brain axis: microbial communities in the intestines influence the synthesis, availability and regulation of these mood-related chemicals. Understanding which chemical pathways may be underperforming can guide more personalized, evidence-based strategies.

Key neurotransmitters linked to low mood

Serotonin regulates mood, appetite and sleep; dopamine supports motivation and reward; GABA reduces neural excitability and calms anxiety; and norepinephrine contributes to alertness and energy. Deficits in any of these systems can contribute to depressive symptoms, but these deficits are often downstream effects of metabolic, inflammatory or microbial imbalances rather than isolated brain-only problems.

The gut’s contribution

Approximately 90% of the body’s serotonin is produced in the gut, and multiple bacterial taxa influence precursor availability and host signaling pathways. For example, Bifidobacterium infantis and certain Lactobacillus species have been associated with improved tryptophan metabolism and changes in host serotonin signaling. Short-chain fatty acids (SCFAs), produced by fiber-fermenting bacteria such as Faecalibacterium prausnitzii, also modulate inflammation and barrier integrity, which indirectly affect neurotransmitter balance.

For a concise primer on how different microbial communities are categorized, see this discussion of the three types of microbiome. To explore a specific strain linked to gut-brain interactions, review the research summary on Bifidobacterium infantis, which highlights mechanisms relevant to tryptophan and serotonin pathways.

Testing to identify likely deficits

Gut microbiome testing can identify dysbiosis, low microbial diversity or absence of taxa that support neurotransmitter precursors. Such tests often report on metabolite markers (e.g., SCFAs) and taxa associated with neuromodulatory functions. Interpreting these results alongside dietary, inflammatory and clinical data helps clarify whether low mood may relate to impaired peripheral synthesis or signaling of depression-related chemicals. For an integrated perspective, review this overview of Bifidobacterium infantis research.

Translating findings into balanced approaches

When testing suggests microbial contributions to neurotransmitter imbalance, interventions are typically multimodal: dietary adjustments to increase fermentable fiber and polyphenols, targeted probiotic strains with documented neuroactive effects, amino acid precursors when indicated, and lifestyle measures to reduce inflammation and support the gut barrier. For guidance on linking microbiome results to actionable steps, consult this resource on which chemical you may be lacking in depression. A general product-oriented test platform can also provide structured microbial profiling reports (microbiome test).

Conclusions

No single chemical fully explains depression. Emerging data indicate that gut microbiota shape multiple neurotransmitter systems simultaneously, and that microbiome-informed assessment can reveal biological contributors to mood disorders. Integrating microbial profiling with clinical evaluation supports targeted, evidence-based approaches that address root mechanisms rather than only symptomatic suppression.